Contribution of BCR-ABL-independent activation of ERK1/2 to acquired imatinib resistance in K562 chronic myeloid leukemia cells (Q43258249)

From Wikidata
Jump to navigation Jump to search
scientific article published on 14 September 2009
edit
Language Label Description Also known as
English
Contribution of BCR-ABL-independent activation of ERK1/2 to acquired imatinib resistance in K562 chronic myeloid leukemia cells
scientific article published on 14 September 2009

    Statements

    Contribution of BCR-ABL-independent activation of ERK1/2 to acquired imatinib resistance in K562 chronic myeloid leukemia cells (English)
    Takeru Nambu
    Norie Araki
    Aiko Nakagawa
    Akihiko Kuniyasu
    Tatsuya Kawaguchi
    Akinobu Hamada
    Hideyuki Saito
    14 September 2009
    137-142

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit